SEQUENOM INC. NEW läuft weiter megamässsig!!

..jeiha

www.sequenom.com/invest/corporate-governance GrB

Dschorannimo iss RAUS ..unddd BASTA ..ha

Kosmonova buran

board@sequenom.com
www.sequenom.com/invest/corporate-governance

..so buran?

..übel übel riech

Kosmonova buran

www.sequenom.com/invest/analyst-coverage GrB

www.sequenom.com/invest/stock-information GrB

..yöah

www.sequenom.com/invest/stock-information GrB

www.sequenom.com/invest/stock-information GrB

..yöah

www.sequenom.com/invest/sec-filings GrB

..yöah

www.sequenom.com/invest/financial-reports GrB

www.sequenom.com/invest/financial-reports GrB
 

..yöah

bhoa...

www.sequenom.com/invest/fundamentals GrB

www.sequenom.com/press GrB

ILLUMINA AND SEQUENOM POOL NONINVASIVE PRENATAL TESTING INTELLECTUAL PROPERTY AND END OUTSTANDING PATENT DISPUTES www.sequenom.com/press/...esting-intellectual-property-and-end

..yöah

..juha

worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents. In addition, Sequenom and Illumina will each have rights to utilize all pooled patents to develop and sell their own respective laboratory-developed NIPT tests. The parties will share the revenue from the patent pool and Illumina will pay Sequenom a royalty on sales of in-vitro diagnostic kits for NIPT. www.sequenom.com/press/...esting-intellectual-property-and-end

man man Dschorannimo

Kosmonova buran